Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Internat Operation LufiledCriticalMenarini Internat Operation Lu
Priority to MXPA05013701priorityCriticalpatent/MXPA05013701A/en
Publication of MXPA05013701ApublicationCriticalpatent/MXPA05013701A/en
Described are oral dosage forms containing zofenopril calcium salts, and mainly solid oral dosage forms containing a combination of zofenopril, as polymorph A substantially pure from polymorph B, and hydrochlorothiazide (HCTZ), the invention also including processes for preparing the same.
MXPA050137012005-12-152005-12-15Pharmaceutical composition containing zofenopril and hctz for treating hypertension.
MXPA05013701A
(en)